Michael R. Hayden, Director at Xenon, holds 37.22K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 1.44M shares in AbCellera Biologics (Ticker: ABCL), holds 142.44K shares in 89bio (Ticker: ETNB). Most recently, Michael R. Hayden Bought ― shares of Ionis Pharmaceuticals on Dec 26, 2024 for an estimated value of 181.05K.
What is the percentage of profitable transactions made by Michael R. Hayden?
The percentage of profitable transactions made by Michael R. Hayden is 27%.
What is the average return per transaction made by Michael R. Hayden?
The average return per transaction made by Michael R. Hayden is 7.70%.
What stocks does Michael R. Hayden hold?
Michael R. Hayden holds: XENE, IONS, ETNB, ABCL stocks.
What was Michael R. Hayden’s latest transaction?
Michael R. Hayden latest transaction was an Informative Buy of $181.05K.
What was Michael R. Hayden's most profitable transaction?
Michael R. Hayden’s most profitable transaction was an Informative Buy of XENE stock on August 14, 2017. The return on the trade was 356.00%.
What is Michael R. Hayden's role in Xenon?
Michael R. Hayden's role in Xenon is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.